These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 6548238

  • 21. A overview of ocular leprosy after 2 decades of multidrug therapy.
    Lewallen S, Courtright P.
    Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
    [No Abstract] [Full Text] [Related]

  • 22. Chemotherapy of leprosy for control programmes: scientific basis and practical application.
    Rees RJ.
    Lepr Rev; 1983 Jun; 54(2):81-7. PubMed ID: 6888143
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Multidrug therapy (MDT) and leprosy control.
    Noordeen SK.
    Indian J Lepr; 1990 Jun; 62(4):448-58. PubMed ID: 2086680
    [No Abstract] [Full Text] [Related]

  • 26. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR, Spencer TI, Ladizinski B.
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract] [Full Text] [Related]

  • 27. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S, Leguizamón OR, Alvarenga AE.
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Combination drug therapy in leprosy].
    Terencio de las Aguas J.
    Acta Leprol; 1983 Jun; 1(3):143-50. PubMed ID: 6359802
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. THELEP controlled clinical trials in lepromatous leprosy.
    Lepr Rev; 1983 Sep; 54(3):167-76. PubMed ID: 6355720
    [No Abstract] [Full Text] [Related]

  • 32. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
    Winsley BE, McDougall AC, Brown KE.
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
    [No Abstract] [Full Text] [Related]

  • 33. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
    Kumar B, Kaur S, Kaur I.
    Indian J Lepr; 1987 Dec; 59(1):54-62. PubMed ID: 3302061
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
    Jacobson RR, Gatt P.
    Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rifampicin and isoprodian in combination in the treatment of leprosy.
    Depasquale G.
    Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
    [No Abstract] [Full Text] [Related]

  • 39. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL, Araujo S, Stryjewska BM, Scollard D.
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.